[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69939833D1 - Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon - Google Patents

Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon

Info

Publication number
DE69939833D1
DE69939833D1 DE69939833T DE69939833T DE69939833D1 DE 69939833 D1 DE69939833 D1 DE 69939833D1 DE 69939833 T DE69939833 T DE 69939833T DE 69939833 T DE69939833 T DE 69939833T DE 69939833 D1 DE69939833 D1 DE 69939833D1
Authority
DE
Germany
Prior art keywords
tumor antigen
new
antigen protein
peptide
protein sart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939833T
Other languages
English (en)
Inventor
Kyogo Itoh
Masanobu Nakao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Green Peptide Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69939833D1 publication Critical patent/DE69939833D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69939833T 1998-08-28 1999-08-27 Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon Expired - Lifetime DE69939833D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24266098 1998-08-28
PCT/JP1999/004622 WO2000012701A1 (fr) 1998-08-28 1999-08-27 Nouvelle proteine d'antigene tumoral sart-3 et peptide d'antigene tumoral de celle-ci

Publications (1)

Publication Number Publication Date
DE69939833D1 true DE69939833D1 (de) 2008-12-11

Family

ID=17092354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939833T Expired - Lifetime DE69939833D1 (de) 1998-08-28 1999-08-27 Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon

Country Status (14)

Country Link
US (4) US7541428B2 (de)
EP (1) EP1116791B1 (de)
JP (2) JP4436977B2 (de)
KR (1) KR100660367B1 (de)
CN (1) CN1264980C (de)
AT (1) ATE412747T1 (de)
AU (1) AU762516B2 (de)
CA (1) CA2340888C (de)
DE (1) DE69939833D1 (de)
ES (1) ES2316191T3 (de)
HK (1) HK1041290B (de)
ID (1) ID29405A (de)
NZ (1) NZ510154A (de)
WO (1) WO2000012701A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69939833D1 (de) * 1998-08-28 2008-12-11 Kyogo Itoh Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon
JP2002365286A (ja) * 2000-11-13 2002-12-18 Kyogo Ito 細胞性免疫検出法およびその医薬への応用
EP1473564A4 (de) * 2001-09-18 2008-12-10 Greenpeptide Co Ltd Verfahren zum nachweis von zellimmunität und dessen anwendung auf arzneistoffe
WO2005011723A1 (ja) * 2003-08-05 2005-02-10 Green Peptide Co., Ltd. 造血器腫瘍の予防および/または治療剤
CA2538300A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
WO2008007711A1 (fr) * 2006-07-11 2008-01-17 Kurume University Peptide dérivé de sart3, utile dans une thérapie du cancer par vaccin pour patient présentant un cancer de la prostate, positif á l'allèle hla-supertype a3
CN101854945B (zh) 2007-09-18 2015-07-01 株式会社绿多肽 Ctl诱导剂组合物
EP2591799B1 (de) 2010-07-07 2017-03-08 Green Peptide Co., Ltd. Krebspeptid-impfstoff
BR112015021162A2 (pt) 2013-03-08 2017-10-10 Taiho Pharmaceutical Co Ltd peptídeo tendo 5 epítopos de ctl ligados
AU2014337643B2 (en) * 2013-10-21 2017-07-13 Taiho Pharmaceutical Co., Ltd. Novel four-CTL epitope-joined peptide
KR20210024601A (ko) 2018-06-29 2021-03-05 다이호야쿠힌고교 가부시키가이샤 항종양제 및 그 평가방법
AU2020411439A1 (en) 2019-12-26 2022-08-04 Taiho Pharmaceutical Co., Ltd. Agent for adjuvant therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ271774A (en) 1993-08-06 1998-02-26 Cytel Corp Immunogenic peptides from the c-terminus of the mage-1 (melanoma) antigen
CN1203177C (zh) 1996-06-07 2005-05-25 伊东恭悟 肿瘤抗原蛋白质及其基因和肿瘤抗原肽
DE69939833D1 (de) * 1998-08-28 2008-12-11 Kyogo Itoh Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US20060035251A1 (en) 2004-06-30 2006-02-16 Whitehead Institute For Biomedical Research Novel methods for high-throughput genome-wide location analysis

Also Published As

Publication number Publication date
KR20010074895A (ko) 2001-08-09
JP4904384B2 (ja) 2012-03-28
ID29405A (id) 2001-08-30
US20120123090A1 (en) 2012-05-17
NZ510154A (en) 2002-11-26
CN1324404A (zh) 2001-11-28
US7541428B2 (en) 2009-06-02
EP1116791A4 (de) 2002-01-09
HK1041290B (zh) 2007-03-09
US20060140968A1 (en) 2006-06-29
US8097697B2 (en) 2012-01-17
AU5444199A (en) 2000-03-21
US7968676B2 (en) 2011-06-28
AU762516B2 (en) 2003-06-26
US20110243974A1 (en) 2011-10-06
JP4436977B2 (ja) 2010-03-24
KR100660367B1 (ko) 2006-12-21
ES2316191T3 (es) 2009-04-01
US20090297544A1 (en) 2009-12-03
JP2010029194A (ja) 2010-02-12
ATE412747T1 (de) 2008-11-15
WO2000012701A1 (fr) 2000-03-09
CA2340888C (en) 2008-08-05
EP1116791A1 (de) 2001-07-18
US8563684B2 (en) 2013-10-22
EP1116791B1 (de) 2008-10-29
CA2340888A1 (en) 2000-03-09
CN1264980C (zh) 2006-07-19
HK1041290A1 (en) 2002-07-05

Similar Documents

Publication Publication Date Title
DE69937294D1 (de) Von cyclophilin b abstammende tumorantigen-peptide
ATE197307T1 (de) Neuroaktive peptide
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
CY1114164T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
HK1049848A1 (zh) 用於治療和診斷肺癌的化合物和方法
ATE412747T1 (de) Neues tumor-antigen-protein sart-3 und tumor- antigen-peptid davon
EP0911397A4 (de) Tumorantigenproteine, deren gene, sowie tumorantigenpeptide
ATE397081T1 (de) Erhöhte expression von proteinen mittels gfp
DE69704269D1 (de) Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
NZ331398A (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
DE69930942D1 (de) Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
ATE243502T1 (de) Verwendung von mikropartikeln, auf denen ein protein und ein antikörper adsorbiert sind, zur herstellung eines arzneimittels zur intranasalen verabreichung
EP1792988A3 (de) Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs
WO2003044160A3 (en) Novel molecules of the card related protein family and uses thereof

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GREEN PEPTIDE CO., LTD., KURUME, FUKUOKA, JP

8364 No opposition during term of opposition